Skip to main content
SpringerLink
Log in

Serum prostate specific antigen levels in women with polycystic ovary syndrome and the effect of flutamide+desogestrel/ethinyl estradiol combination

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Background: Prostate-specific antigen (PSA) is expressed in many female tissues and its concentrations were higher in hirsute subjects. We aimed to determine serum PSA level in hirsute women and evaluate the effect of flutamide+ desogestrel/ethynil estradiol combination. Subjects and study design: Thirty patients with polycystic ovary syndrome (PCOS) and 30 healthy controls were studied. Hirsutism was defined by modified Ferriman-Gallwey score (FGS). Free androgen index (FAI) was used for hyperandrogenism. Patients received flutamide (500 mg/d) and oral contraceptive (desogestrel+ethinyl estradiol) for 9 months. Results: Mean FGS (p<0.0001), insulin (p<0.01), FAI (0.0001), androstenedione (p<0.0001), LH (p<0.05), and free testosterone (p<0.003) levels of patients with PCOS were higher than the control group. Mean serum total and free PSA level of PCOS patients were higher than the control group (p<0.0001 and p<0.0001). We found a positive correlation between total PSA levels and FGS (r=0.568, p<0.001), FAI and FGS (r=0.456 and p<0.01). There was also a positive correlation between FAI and total PSA (r=0.503 and p<0.005). At the end of treatment, FGS, androstenedione, free and total testosterone, FAI, serum PSA and LH levels decreased significantly [serum total PSA was 0,0208±0,0178 ng/ml at baseline and 0,0061±0,0044 ng/ml after treatment (p<0.0001)]. Conclusions: 1. Serum prostate specific antigen level is higher in patients with PCOS; 2. There is a positive correlation among FGS, FAI and PSA levels; 3. Serum PSA levels decrease with antiandrogen treatment; 4. Serum PSA mea-surement might be a marker for hirsutism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998, 83: 3078–82.

    CAS  PubMed  Google Scholar 

  2. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961, 21: 1440–7.

    Article  CAS  PubMed  Google Scholar 

  3. Muderris II, Bayram F. Clinical efficacy of lower dose flutamide 125 mg/day in the treatment of hirsutism. J Endocrinol Invest 1999, 22: 165–8.

    Article  CAS  PubMed  Google Scholar 

  4. Falsetti L, Gambera A, Platto C, Legrenzi L. Management of hirsutism. Am J Clin Dermatol 2000, 1: 89–99.

    Article  CAS  PubMed  Google Scholar 

  5. Negri C, Tosi F, Dorizzi R, et al. Antiandrogen drugs lower serum prostate-specific antigen (PSA) levels in hirsute subjects: evidence that serum PSA is a marker of androgen action in women. J Clin Endocrinol Metab 2000, 85: 81–4.

    CAS  PubMed  Google Scholar 

  6. Yu H, Berkel H. Prostate-specific antigen (PSA) in women. J La State Med Soc 1999, 151: 209–13.

    CAS  PubMed  Google Scholar 

  7. Melegos DN, Yu H, Ashok M, Wang C, Stanczyk F, Diamandis EP. Prostate-specific antigen in female serum, a potential new marker of androgen excess. J Clin Endocrinol Metab 1997, 82: 777–80.

    Article  CAS  PubMed  Google Scholar 

  8. Diamandis EP, Yu H. Nonprostatic sources of prostatespecific antigen. Urol Clin North Am 1997, 24: 275–82.

    Article  CAS  PubMed  Google Scholar 

  9. Homburg R. Polycystic ovary syndrome - from gynaecological curiosity to multisystem endocrinopathy. Hum Reprod 1996, 11: 29–39.

    Article  CAS  PubMed  Google Scholar 

  10. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999, 84: 3666–72.

    Article  CAS  PubMed  Google Scholar 

  11. Manetti L, Lupi I, Bogazzi F, et al. Prostate-specific antigen is increased in female patients with Cushing’s disease. J Endocrinol Invest 2002, 25: RC29–31.

    Article  CAS  PubMed  Google Scholar 

  12. Obiezu CV, Scorilas A, Magklara A, et al. Prostate-specific antigen and human glandular kallikrein 2 are markedly elevated in urine of patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2001, 86: 1558–61.

    Article  CAS  PubMed  Google Scholar 

  13. Simard J, Luthy I, Guay J, Belanger A, Labrie F. Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues. Mol Cell Endocrinol 1986, 44: 261–70.

    Article  CAS  PubMed  Google Scholar 

  14. Darney PD. The androgenicity of progestins. Am J Med 1995, 98: 104S–10.

    Article  CAS  PubMed  Google Scholar 

  15. Moghetti P, Castello R, Negri C, et al. Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes, and androgen receptor behavior. Fertil Steril 1995, 64: 511–7.

    CAS  PubMed  Google Scholar 

  16. Dodin S, Faure N, Cédrin I, et al. Clinical efficacy and safety of low-dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism. Clin Endocrinol (Oxf) 1995, 43: 575–82.

    Article  CAS  Google Scholar 

  17. Ciotta L, Cianci A, Marletta E, Pisana L, Agliano A, Palumbo G. Treatment of hirsutism with flutamide and a low-dosage oral contraceptive in polycystic ovary syndrome. Fertil Steril 1994, 62: 1129–35.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology and Metabolism, Dicle University, School of Medicine, 21280, Diyarbakir, Turkey

    M. Bahceci, M. Bilge & A. Tuzcu

  2. Department of Nuclear Medicine, Dicle University, School of Medicine, Diyarbakir, Turkey

    S. Tuzcu

  3. Department of Histology and Embryology, Dicle University, School of Medicine, Diyarbakir, Turkey

    S. Bahceci

Authors
  1. M. Bahceci
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Bilge
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Tuzcu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Tuzcu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Bahceci
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Bahceci.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bahceci, M., Bilge, M., Tuzcu, A. et al. Serum prostate specific antigen levels in women with polycystic ovary syndrome and the effect of flutamide+desogestrel/ethinyl estradiol combination. J Endocrinol Invest 27, 353–356 (2004). https://doi.org/10.1007/BF03351061

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03351061

Key-words

Search

Navigation